Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$59.21 - $78.66 $404,167 - $536,933
-6,826 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $350,788 - $456,659
6,826 New
6,826 $432,000
Q4 2019

Feb 14, 2020

SELL
$19.57 - $28.96 $161,021 - $238,282
-8,228 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$26.92 - $42.41 $221,497 - $348,949
8,228 New
8,228 $221,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.